FDA Food recall F-0463-2024
ACTIRON Dietary Supplement, ActiPharma, 100 tablets (24 bottles per case) ) (Lot 13309, Exp.: 01/26), UPC: 363102217104
- FDA Food
- Class III
- terminated
- Published 2023-11-29
On 2023-11-29 the FDA classified a Class III recall of ACTIRON Dietary Supplement, ActiPharma, 100 tablets (24 bottles per case) ) (Lot 13309, Exp.: 01/26), UPC: 363102217104 by Actipharma, citing FDA sample analysis of ACTIRON Dietary Supplement, 100 Tablets, Lot 13309, found the product did not meet folic acid specification compared to the label claim.
Read the official FDA Food notice
| Agency | FDA Food |
|---|---|
| Recall number | F-0463-2024 |
| Classification | Class III |
| Status | terminated |
| Initiated | 2023-09-28 |
| Published | 2023-11-29 |
| Last updated | 2026-09-13 11:50 UTC |
| Company | Actipharma |
| Distribution | PR |
Product
ACTIRON Dietary Supplement, ActiPharma, 100 tablets (24 bottles per case) ) (Lot 13309, Exp.: 01/26), UPC: 363102217104.
Reason
FDA sample analysis of ACTIRON Dietary Supplement, 100 Tablets, Lot 13309, found the product did not meet folic acid specification compared to the label claim.
Identifiers
| upc | 363102217104 |
|---|---|
| code_info | Lot 13309, Exp: 01/26 |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:50 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/food/enforcement.json?search=recall_number:%22F-0463-2024%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.